Kelly Burdge is a Nephrology physician. OpenAlex indexes 6 publications with 3,298 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
104 Endicott St
Suite 104
Danvers, MA 019233623
Telephone
978-882-6700Registry record last updated 29 Feb 2012.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70%Loop diuretic25.3%Furosemide88%Torsemide12%Part D≥128 patientsAngiotensin receptor blocker (ARB)14.3%Losartan Potassium70%Valsartan18%Olmesartan Medoxomil12%Part D<11 patients+ 8 more classes in this area
Metabolism & gastrointestinal
17.4%SGLT2 inhibitor15.8%Farxiga84%Jardiance10%Dapagliflozin7%Part D<11 patientsVitamin D3 Analog0.8%Calcitriol100%Part D<11 patients+ 1 more class in this area
Genitourinary & hormones
5.7%alpha-Adrenergic Blocker5.7%Tamsulosin Hcl100%Part D≥30 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Merkel Cell Carcinoma Preceding Renal Primary Amyloidosis: Coincidence or Causality?
Journal of the American Society of Nephrology
2024 - KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Kidney International
2021 - Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Kidney International
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”